The Enteric Glia as a Possible Target for Symptom Relief in Endometriosis
Project Number5R16GM149365-02
Contact PI/Project LeaderAPPLEYARD, CAROLINE B
Awardee OrganizationPONCE SCHOOL OF MEDICINE
Description
Abstract Text
Endometriosis, a chronic painful gynecological disorder defined as the presence of endometrial glands
and stroma outside the endometrial cavity, is characterized by peritoneal inflammation, fibrosis, adhesions,
and ovarian cysts. Women with endometriosis often present gastrointestinal symptoms independent of
lesion localization. Enteric glial cells (EGCs) are astrocyte-like cells that are vital to the enteric nervous
system and play a role in gut diseases. The role of intestinal glia in endometriosis is unknown; however, a
bidirectional relationship between the EGC and immune cells in the modulation of the inflammatory
response and pain sensitization is postulated. Enteric glia can produce an endogenous ligand for
peroxisome proliferator activated receptor gamma (PPAR) with anti-inflammatory activity. PPAR
agonists in endometriosis animal models reduce vesicle size. The study team’s previous work has
demonstrated that exercise can increase expression and activity of PPAR, while reducing vesicle size
and development. The main objective is to examine the role of EGC in the pathophysiology of
endometriosis with the long-term goal of finding new therapeutic targets. The study team hypothesizes that
endometriosis-induced immune activation is regulated by ECG which promotes and maintains chronic
inflammation, and that this can be reversed by non-pharmacological complementary interventions. Aim 1
will determine how endometriosis impacts the enteric glia and how this correlates with pain. Aim 2 will
elucidate whether the beneficial effects of interventions, such as exercise and environmental enrichment,
are mediated by PPAR. Rationale: complementary interventions will impact the enteric glia via
parasympathetic activation, shifting it from the endometriosis-induced, pro-inflammatory phenotype to an
anti-inflammatory one, decreasing proinflammatory cytokine release and oxidative stress.
Successful outcomes could explain chronic pelvic inflammation and gastrointestinal symptoms and
provide a novel target. This study will contribute to the goals of the SuRE program by sustaining the
research excellence of the PI and strengthening the institutional research environment. This study will
provide graduate and undergraduate students at various levels with opportunities in multidisciplinary
research areas to encourage their continued involvement in biomedical sciences research and stimulate
their interest in novel integrative interventions.
Public Health Relevance Statement
Endometriosis is a poorly understood painful condition that incapacitates and affects the productivity and
well-being of millions of women around the world. Symptoms of this disease are considered significant
sources of stress occurring throughout the reproductive life of these patients. This study will reveal novel
therapeutic approaches for patients with endometriosis by creating a new area of investigation for better
treatments that could improve women’s health.
No Sub Projects information available for 5R16GM149365-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R16GM149365-02
Patents
No Patents information available for 5R16GM149365-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R16GM149365-02
Clinical Studies
No Clinical Studies information available for 5R16GM149365-02
News and More
Related News Releases
No news release information available for 5R16GM149365-02
History
No Historical information available for 5R16GM149365-02
Similar Projects
No Similar Projects information available for 5R16GM149365-02